Silo Pharma, Inc (OTCQB:SILO) CEO, Eric Weisblum presents at Proactive's One2One virtual investor forum.
Silo Pharma is bridging the gap between traditional pharmaceuticals and the emerging psychedelics space. The developmental-stage biopharmaceutical company’s mission is to identify assets to license and fund the research which it believes could transform both the well-being of patients and the healthcare system at large.